相关实验视频

Updated: Jun 15, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

在急性髓性白血病的免疫治疗中针对PARP的治疗向

Xing Bian¹, Wenli Liu², Kaijin Yang³

¹College of Biological and Pharmaceutical Engineering, West Anhui University, Lu'an, China.

Frontiers in pharmacology

|August 23, 2024

概括

多 (ADP-ribose) 聚合酶抑制剂单独在急性髓性白血病 (AML) 中表现出适度的疗效,但与化疗有协同作用. PARP 抑制剂还通过增加瘤突变负担来增强免疫疗法,这表明AML治疗的联合策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症治疗方法癌症治疗方法

背景情况:

多 (ADP-ribose) 聚合酶 (PARP) 抑制剂在具有同源重组 (HR) 缺陷的BRCA突变癌症中有效.
急性髓性白血病 (AML) 通常具有有限的BRCA突变,这表明单独使用PARP抑制剂 (PARPi) 的有效性有限.
最近的研究表明,PARPi单一治疗在AML中的疗效有限,但与细胞毒性化疗具有显著的协同效应.

研究的目的:

审查PARP蛋白在与AML相关的DNA损伤反应 (DDR) 途径中的作用.
讨论使用PARPi在AML中的合成致死性方法的临床前证据.
探索PARPi在AML中的免疫调节作用及其对组合疗法的潜力.

主要方法:

在急性髓性白血病模型中对PARP抑制剂进行现有临床前研究的综述.
分析PARPi对DNA损伤反应 (DDR) 途径的影响.
评估PARPi对瘤免疫微环境和突变负担的影响.

主要成果:

在临床前的AML模型中,PARPi单一治疗显示了适度的抗瘤作用.
与细胞毒性化疗相结合的PARPi在AML中显示出显著的协同抗瘤活性.
通过增加瘤突变负担,PARPi促进了免疫调节性瘤微环境,提高了免疫疗法组合的潜力.

结论:

PARPi对白血病治疗有前途,特别是在组合疗法中.
对DNA损伤反应 (DDR) 和瘤免疫微环境的联合向代表了AML未来有前途的治疗策略.
这些组合策略可能会显著有利于接受基于PARPi的癌症治疗的AML患者.

关键词:

在AML,AML就是AML.修复DNA的修复DNA的修复在PARP中,PARP是PARP.免疫疗法是一种免疫疗法.有协同作用的效应.

更多相关视频

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.